AZD8529

DB16073InvestigationalSmall molecule

AZD8529 is under investigation in clinical trial NCT00921804 (Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients).

Formula / weight: C₂₄H₂₄F₃N₅O₃ · 487.483 g/mol (avg)
Code names: AZD-8529

Resolves to

Compound

UNII6H81G454I7CAS1092453-15-0ChEMBLCHEMBL3937907

Structure

InChIKeyIPCYZQQFECEHLI-UHFFFAOYSA-NSMILESCC1=CC(=CC2=C1C(=O)N(CC1=CC=C(OC(F)(F)F)C=C1)C2)C1=NC(CN2CCNCC2)=NO1

Targets

Q13255GRM1

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with AZD8529, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account